ClinConnect ClinConnect Logo
Search / Trial NCT07006389

Factors Affecting Response to Extracorporeal Shock Wave Therapy in Plantar Fasciitis: A Cross-sectional Clinical Study

Launched by SISLI HAMIDIYE ETFAL TRAINING AND RESEARCH HOSPITAL · May 27, 2025

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Pain Plantar Fasciitis Plantar Heel Pain Eswt Extracorporeal Shock Wave Therapy

ClinConnect Summary

Plantar heel pain is one of the reasons that affect daily life activities. There are many treatment methods for this. Extracorporeal shock wave therapy (ESWT) is one of them. However, some patients do not respond to ESWT treatment. In this study, patients were divided into 2 groups as those who did not respond to ESWT treatment in terms of pain (less than 50% decrease in pain level) or those with recurrence of pain and those who responded to treatment. Patients who had passed 3-6 months after ESWT constituted the study groups. These two groups will be compared in terms of age, gender, occup...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • \>18 years
  • Unresponsive to conservative treatments (physical therapy, rest, exercises, anti-inflammatory medical treatment, insoles, etc.)
  • Patients who have received ESWT treatment and 3-6 months have passed since ESWT
  • Exclusion Criteria:
  • History of injection therapy including steroids after ESWT treatment
  • Those taking NSAIDs in the last 2 weeks
  • Those with a history of trauma or surgery to the foot or ankle
  • Presence of rheumatic disease affecting the foot or ankle (e.g. spondyloarthritis, etc.)
  • Malignancy
  • Pregnancy

About Sisli Hamidiye Etfal Training And Research Hospital

Sisli Hamidiye Etfal Training and Research Hospital is a prominent healthcare institution dedicated to advancing medical research and education. Located in Istanbul, Turkey, the hospital is affiliated with the Ministry of Health and serves as a leading center for clinical trials, providing comprehensive services in various medical specialties. With a strong commitment to improving patient outcomes and contributing to scientific knowledge, Sisli Hamidiye Etfal fosters collaboration among healthcare professionals, researchers, and academic institutions. The hospital is equipped with state-of-the-art facilities and adheres to the highest ethical standards, ensuring the integrity and safety of its clinical research initiatives.

Locations

İstanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Banu Kuran, Professor, MD

Study Director

Şişli Hamidiye Etfal Taining and Research Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported